148 related articles for article (PubMed ID: 37106444)
1. Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
Zhang HW; Zhong XM; Zhang ZH; Pang HW
BMC Cancer; 2023 Apr; 23(1):385. PubMed ID: 37106444
[TBL] [Abstract][Full Text] [Related]
2. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
[TBL] [Abstract][Full Text] [Related]
3. Improving plan quality in cervical brachytherapy using a simple knowledge-based prediction tool for OAR dose (D2cm
Flower E; Sykes J; Sullivan E; Busuttil G; Thiruthaneeswaran N; Cosgriff E; Chard J; Salkeld A; Thwaites D
Brachytherapy; 2023; 22(5):623-629. PubMed ID: 37296007
[TBL] [Abstract][Full Text] [Related]
4. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
5. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
6. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
8. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
9. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
10. Should the organs at risk be contoured in vaginal cuff brachytherapy?
Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
[TBL] [Abstract][Full Text] [Related]
11. Support Vector Machine Model Predicts Dose for Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer.
Zhou P; Li X; Zhou H; Fu X; Liu B; Zhang Y; Lin S; Pang H
Front Oncol; 2021; 11():619384. PubMed ID: 34336640
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-based three-dimensional dose prediction for tandem-and-ovoid brachytherapy.
Cortes KG; Kallis K; Simon A; Mayadev J; Meyers SM; Moore KL
Brachytherapy; 2022; 21(4):532-542. PubMed ID: 35562285
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric and Radiobiological Evaluation of Hybrid Inverse Planning and Optimization for Cervical Cancer Brachytherapy.
Matias Ldos S; Palmqvist T; Wolke J; Nilsson J; Beskow C; Maphossa AM; Toma-Dasu I
Anticancer Res; 2015 Nov; 35(11):6091-6. PubMed ID: 26504034
[TBL] [Abstract][Full Text] [Related]
14. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
[TBL] [Abstract][Full Text] [Related]
15. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
[TBL] [Abstract][Full Text] [Related]
16. MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy.
Dolezel M; Odrazka K; Vanasek J; Kohlova T; Kroulik T; Kudelka K; Spitzer D; Mrklovsky M; Tichy M; Zizka J; Jalcova L
Br J Radiol; 2011 Sep; 84(1005):850-6. PubMed ID: 21849368
[TBL] [Abstract][Full Text] [Related]
17. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
[TBL] [Abstract][Full Text] [Related]
19. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
20. RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
Mao X; Pineau J; Keyes R; Enger SA
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):802-812. PubMed ID: 32413546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
